Clinical Trial Update: Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating haloperidol to prevent progression from ICU subsyndromal delirium to delirium. Study status indicates the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Subsyndromal Delirium

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Northeastern University | Conditions: Subsyndromal Delirium | Phase 4 | Status: COMPLETED